C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/445 (2006.01) C07D 401/00 (2006.01) C07D 405/14 (2006.01)
Patent
CA 2427619
Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF.alpha.. A typical embodiment is 2-(2,6- dioxo-3-hydroxy-5-fluoro-piperidin-5-yl)-4-aminoisoindolin-1-one.
Isoindolin-1-one et isoindolin-1,3-dione substitués en position 2 par un groupe 2,6-dioxo-3-hydroxypipéridin-5-yle, qui peut être ultérieurement substitué en position 5 avec un alkyle ou un halogéno-, et en position 5 avec un alkyle ou un groupe contenant l'azote; en tant qu'inhibiteurs de TNF.alpha., ils sont utiles dans le traitement des états pathologiques à médiation par TNF.alpha.. Un mode de réalisation type est le 2-(2,6-dioxo-3-hydroxy-5-fluoro-pipéridin-5-yl)-4-amino-isoindolin-1-one.
Man Hon-Wah
Muller George W.
Stirling David I.
Celgene Corporation
Smart & Biggar
LandOfFree
Pharmaceutically active isoindoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically active isoindoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active isoindoline derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1601173